Deadline: 9 March 2016
Applications are open for the Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) by Department of Health and Human Services with a motive to facilitate the translation of sufficiently advanced, innovative and promising vaccine candidates into early clinical testing.
The IPCAVD program is designed to enable a multi-disciplinary team of investigators to complete all steps necessary from down-selection of a vaccine candidate through CGMP manufacture/testing/product release and into clinical trials.
Specifically the IPCAVD award will provide support for:
- all stages of vaccine platform research and development through facilitation of Non-Human Primate (NHP) proof-of concept studies and down-selection of the final lead candidate;
- all product development stages including processes development, CGMP manufacturing and formulation;
- support for all IND-enabling studies and regulatory submissions.
Eligibility Criteria
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits Other Than Institutions of Higher Education
- For-Profit Organizations
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- S. Territory or Possession
- Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
- Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
How to Apply
Interested applicants must submit their applications electronically at the address given on the website.
For more information, please visit AIDS Vaccine Development Program.
